G. Nishikawa

Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice.

M. Taketo, H. Hirai, Y. Sakai, 2020, Cancer letters.

Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer

R. Takahashi, Y. Sakai, K. Kawada, 2017, International journal of molecular sciences.

Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer.

K. Obama, M. Taketo, S. Shirasawa, 2021, Cancer letters.

Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells

K. Obama, M. Taketo, H. Miyoshi, 2022, Cells.

Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5

Y. Sakai, K. Kawada, Y. Itatani, 2019, Cell death & disease.

Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8–CXCR2 Axis

H. Hirai, Y. Sakai, K. Kawada, 2019, Clinical Cancer Research.

Laparoscopic pelvic sidewall dissection with combined resection of internal iliac vessels for local recurrence of rectal cancer

K. Hida, Y. Sakai, S. Hasegawa, 2015, Techniques in Coloproctology.

Orally Bioavailable Quinoxaline Inhibitors of 15-Prostaglandin Dehydrogenase (15-PGDH) Promote Tissue Repair and Regeneration.

S. Markowitz, B. Hu, Dawn Dawson, 2022, Journal of medicinal chemistry.